Related Experiment Video

Updated: Aug 11, 2026

Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents
09:28

Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents

Published on: September 16, 2020

Reoxygenation in the RIF-1 tumor

M J Dorie, R F Kallman

    International Journal of Radiation Oncology, Biology, Physics
    |May 1, 1984
    PubMed

    Abstract:

    The proportion of hypoxic cells in the RIF-1 tumor was examined for 13 days following a 15 Gy conditioning dose. The paired survival curve technique indicated that 100% of the surviving cells were hypoxic immediately following this treatment. However, within 1 hour, only about 50% remained hypoxic; this proportion continued to drop to about 10% but did not reach the pretreatment level of 1.1% for the duration of the study.

    More Related Videos

    Analytical Determination of Mitochondrial Function of Excised Solid Tumor Homogenates
    11:32

    Analytical Determination of Mitochondrial Function of Excised Solid Tumor Homogenates

    Published on: August 6, 2021

    Tumor Hypoxia Assessment: In Vivo 3D Oxygen Imaging Through Electron Paramagnetic Resonance
    07:07

    Tumor Hypoxia Assessment: In Vivo 3D Oxygen Imaging Through Electron Paramagnetic Resonance

    Published on: February 14, 2025

    Related Experiment Videos

    Last Updated: Aug 11, 2026

    Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents
    09:28

    Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents

    Published on: September 16, 2020

    Analytical Determination of Mitochondrial Function of Excised Solid Tumor Homogenates
    11:32

    Analytical Determination of Mitochondrial Function of Excised Solid Tumor Homogenates

    Published on: August 6, 2021

    Tumor Hypoxia Assessment: In Vivo 3D Oxygen Imaging Through Electron Paramagnetic Resonance
    07:07

    Tumor Hypoxia Assessment: In Vivo 3D Oxygen Imaging Through Electron Paramagnetic Resonance

    Published on: February 14, 2025

    Related Concept Videos

    Rous Sarcoma Virus (RSV) and Cancer01:03

    Rous Sarcoma Virus (RSV) and Cancer

    Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
    RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...

    Articles linked to this work by shared authors, journal, and citation graph.

    Mitochondrial dysfunction after aerobic exposure to the hypoxic cytotoxin tirapazamine.

    Cancer research·2001

    DNA damage measured by the comet assay in head and neck cancer patients treated with tirapazamine.

    Neoplasia (New York, N.Y.)·2000

    Oxygen tension measurements of tumors growing in mice.

    International journal of radiation oncology, biology, physics·1999

    Comparison of the effectiveness of tirapazamine and carbogen with nicotinamide in enhancing the response of a human tumor xenograft to fractionated irradiation.

    Radiation oncology investigations·1999

    1,2,4-Benzotriazine 1,4-dioxides. An important class of hypoxic cytotoxins with antitumor activity.

    Anti-cancer drug design·1998

    Tirapazamine-induced cytotoxicity and DNA damage in transplanted tumors: relationship to tumor hypoxia.

    Cancer research·1997

    A novel lattice technique via adaptive spot assignment and LET optimization based proton arc therapy.

    International journal of radiation oncology, biology, physics·2026

    The Evolution of Radiotherapy in Children's Oncology Group Trials, from 1998-2025.

    International journal of radiation oncology, biology, physics·2026

    Development and Experimental Validation of an Energy Layer-wise Beam Deflection Compensation Method for MR-integrated Proton Therapy with a Transverse Magnetic Field.

    International journal of radiation oncology, biology, physics·2026

    Acute radiation side effects of proton versus photon therapy following surgery for early breast cancer, a sub-study of the randomised controlled DBCG Proton Trial.

    International journal of radiation oncology, biology, physics·2026

    Particle Beam Radiotherapy for Gynecologic Cancers: A Scoping Review and Expert Opinion by the Particle Therapy Cooperative Group - Gynecologic Subcommittee.

    International journal of radiation oncology, biology, physics·2026

    An exploratory analysis of the association between progesterone use and tumor-related visual deficit in women with meningioma.

    International journal of radiation oncology, biology, physics·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us